Flow Cytometry Evaluation of the T-Cell ReceptorVβ Repertoire Among HIV-1 Infected Individuals Before and After Antiretroviral Therapy

被引:0
作者
Carmem Beatriz Wagner Giacoia-Gripp
Ivan Neves
Maria Clara Galhardo
Mariza Gonçalves Morgado
机构
[1] Oswaldo Cruz Institute,Laboratory of AIDS and Molecular Immunology, Department of Immunology
[2] FIOCRUZ,Department of Micro
[3] Evandro Chagas Clinical Research Institute,Immuno
[4] FIOCRUZ,Parasitology
[5] Evandro Chagas Clinical Research Institute,Department of Infectious Diseases
[6] FIOCRUZ,Laboratory of AIDS and Molecular Immunology, Department of Immunology
[7] Oswaldo Cruz Institute,undefined
[8] FIOCRUZ,undefined
来源
Journal of Clinical Immunology | 2005年 / 25卷
关键词
HIV-1; TCR Vα; repertoire; HAART; clonality;
D O I
暂无
中图分类号
学科分类号
摘要
HIV-1 infection leads to serious impairment of the immune system and perturbations in the T cell receptor Vβ repertoire are also described. Immune reconstitution can be potentially achieved in response to HAART. In the present study 10 patients were investigated for the Vβ pattern expression before and after six months of HAART. TCR were analyzed for T CD4+ and CD8+ subsets, separately, by flow cytometry, using a monoclonal antibody set of 24 different Vβ chains. Compared to eight Brazilian healthy controls, no differences in Vβ pattern of expression was observed for patients before or on antiretroviral therapy. Some chains such as Vβ 3, 14, 16, 20 and 21.3 were over utilized by both T subsets, independently of HIV infection and/or antiretroviral treatment, differing from the ones described for individuals of other nationalities. However, when each patient was taken individually, particular alterations were detected for the Vβ gene usage, compared to controls, for all individuals. After treatment, significant Vβ usage changes were observed for seven patients. One or more chains on both T subsets were engaged in this process, defining a preferential oligoclonal profile for TCR repertoire distribution, after HAART. Although no pattern of specific Vβ changes was detected in the circulating T cells, we cannot exclude that differential immune responses to HIV or other important antigens are being focused by these cells.
引用
收藏
页码:116 / 126
页数:10
相关论文
共 50 条
  • [21] Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression
    Zhang, Jiu-Cong
    Zhang, Hong-Jun
    Li, Yuan
    Jing, Dan
    Liu, Qing
    Zhao, Ke
    Liu, Qing-Quan
    Zhuang, Yan
    Kang, Wen-Zhen
    Sun, Yong-Tao
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (05) : 368 - 377
  • [22] Different resistance mutations can be detected simultaneously in the blood and the lung of HIV-1 infected individuals on antiretroviral therapy
    White, NC
    Israel-Biet, D
    Coker, RJ
    Mithcell, DM
    Weber, JN
    Clarke, JR
    JOURNAL OF MEDICAL VIROLOGY, 2004, 72 (03) : 352 - 357
  • [23] Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
    Mezzaroma, I
    Carlesimo, M
    Pinter, E
    Alario, C
    Sacco, G
    Muratori, DS
    Bernardi, ML
    Paganelli, R
    Aiuti, F
    AIDS, 1999, 13 (10) : 1187 - 1193
  • [24] Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?
    Anigilaje, Emmanuel A.
    Aderibigbe, Sunday A.
    Adeoti, Adekunle O.
    Nweke, Nnamdi O.
    PLOS ONE, 2016, 11 (05):
  • [25] T-cell vaccination against anti-CD4 autoimmunity in HIV-1 infected patients
    Abulafia-Lapid, R
    Bentwich, Z
    Keren-Zur, Y
    Cohen, IR
    Atlan, H
    JOURNAL OF CLINICAL VIROLOGY, 2004, 31 : S48 - S54
  • [26] Peripheral immune phenotypes and T cell receptor repertoire in pneumocystis pneumonia in HIV-1 infected patients
    Qiao, Luxin
    Cui, Xiao
    Jia, Lin
    Gao, Yuxue
    Wang, Wenjing
    Wei, Feili
    Zhang, Zhili
    Chen, Dexi
    Ma, Yingmin
    Zhang, Yulin
    CLINICAL IMMUNOLOGY, 2022, 237
  • [27] Complete immune and clinical recovery after highly active antiretroviral therapy in advanced vertically HIV-1 infected children
    Resino, S
    Sánchez-Ramón, S
    Correa, R
    Navarro, ML
    Bellón, JM
    Muñoz-Fernández, MA
    MEDICINA CLINICA, 2003, 120 (11): : 417 - 420
  • [28] Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It
    Steve, Runal John
    Alex, Diviya
    Yesudhason, Binesh Lal
    Prakash, John Antony Jude
    Mathews, Nitty Skari-ah
    Daniel, Dolly
    Ramalingam, Veena Vadhini
    Demosthenes, John Paul
    Ghale, Ben Chirag
    Anantharam, Raghavendran
    Rebekah, Grace
    Rupali, Priscilla
    Varghese, George Mannil
    Kannangai, Rajesh
    CURRENT HIV RESEARCH, 2021, 19 (03) : 277 - 285
  • [29] CD4+ T-Cell Counts and Plasma HIV-1 RNA Levels Beyond 5 Years of Highly Active Antiretroviral Therapy
    Li, Xiuhong
    Margolick, Joseph B.
    Jamieson, Beth D.
    Rinaldo, Charles R.
    Phair, John P.
    Jacobson, Lisa P.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 57 (05) : 421 - 428
  • [30] HIV-1 encephalopathy among perinatally infected children: Neuropathogenesis and response to highly active antiretroviral therapy
    Mitchell, Charles D.
    MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2006, 12 (03): : 216 - 222